News

March 31, 2021

EACS at ISHEID 2021

17 May 2021

YING (EACS Young Investigators) is organising a joint session on HIV & COVID-19 at ISHEID 2021 on 17 May 2021 at 17:30 CEST. ISHEID is taking place virtually from 17-20 May 2021. The symposium will dedicate a privileged place to state-of-the-art presentations, as well as to debates among experienced and younger investigators regarding new data and their implications.

Read more

March 29, 2021

WHO/CDC update on HIV testing: Rationale for not using WB and LIA & what is the best approach.

30 March 2021- 12.00 PM CET time

Based on evidence, in 2019 WHO recommended against the use of western blotting (WB) and line immunoassays (LIA) in routine HIV testing services. These should be replaced with simpler tests in HIV testing services that include rapid diagnostic tests (RDTs) that are easy to use at the point-of-care, and enzyme immunoassays (EIAs).  The CDC recommended HIV testing approach also is based on advances in HIV diagnostic testing and does not rely on WB.

 

This online webinar aims at presenting and discussing the evidence behind the currently recommended approach by WHO and CDC and the context of WHO European Region countries with focus on the East and Centre of the Region. 

Simultaneous translation English/Russian will be provided.

For registration and participation follow the link: https://euro-who.zoom.us/meeting/register/tJwldemrrTsiGN1OO65F8-HFIkOkIbsISNlr

 

March 25, 2021

British HIV Association guidelines on immunisation for adults with HIV: SARS-CoV-2 (COVID-19) 2021 - consultation open

These guidelines aim to provide information for healthcare professionals on the use of SARS-CoV-2 immunisation in people with HIV. They are based on the interpretation of current evidence, and will be kept under review and updated as new evidence emerges.

A non-technical summary is in development.

This consultation will be open for one month until 17:00 on Friday 23 April 2021.

Read more and download the consultation

March 11, 2021

Call for Expression of Interest in hosting the 19th European AIDS Conference, 2023 and/or the 20th European AIDS Conference 2025

The European AIDS Clinical Society (EACS) is issuing a call for Expressions of Interest in hosting the 2023 and/or 2025 Conference(s) to establish a shortlist of a maximum six potential venues/destinations. A different host city/venue will be selected for 2023 and 2025; interested candidates may submit bids for 2023 (submit just 2023 dates) or 2025 (submit just 2025 dates) or for both years (submit dates for both 2023 and 2025). The same city will not be chosen for both years.

Read more

March 4, 2021

18th European AIDS Conference - Save the date!

27-30 October 2021

 

The next biennial European AIDS Conference will be organised as a hybrid meeting in London on 27-30 October, 2021.

Registration, abstract and clinical cases submission will open soon.

For more information

March 3, 2021

European Hector Research Award in HIV 2021

The H.W. & J. Hector Foundation, Weinheim, is announcing a prize for European HIV research, which will be awarded for the best scientific achievements in the HIV research area in 2020.
Any paper on an HIV-related topic that has been accepted or published in a peer-reviewed journal within the last 24 months (i.e. from October 27, 2019) before the start of the 18th European AIDS Conference can be submitted.
More information

March 3, 2021

First WEEPI-funded projects being rolled-out

The Western-Eastern European Partnership Initiative on HIV, viral hepatitis and tuberculosis (WEEPI) awarded its first grants in late summer 2020. Seven ‘stage 1’ projects, covering a range of clinical and implementation research topics across the three disease, have been initiated and are being implemented by project teams in four countries in dialogue with WEEPI-affiliated researchers. The projects are at various stages of implementation but all are in progress despite of the ongoing COVID-19 pandemic.
Read more here

March 3, 2021

EATG PROMS in HIV Research

EATG did research into the use of PROMs for the development of new HIV medicines. Led by the community, the work comprised of a literature review, a survey with people living with HIV taking treatment and stakeholder interviews. The purpose of the work is to describe the current use of PROMs in HIV research and development as well as to inform an advocacy agenda to guide the use and development of PROMs, highlighting the role of communities living with or affected by HIV. It provides a concrete set of recommendations for people living with HIV, pharmaceutical companies, researchers/clinicians and regulatory bodies/HTAs.
Read the full report

15 / 45

20th European AIDS Conference

15-18 October 2025 Paris, France

EACS Guidelines updated

The EACS 12.0 and the app are available for free on

Apple Store and Google Play Store

Read more

Educational Programme

Training and educating the next generation of clinicians and researchers is an EACS core activity.

Read more

EACS Resource Library

Access all scientific content of EACS core activities! (members only)

Read more

New Interim Guidance

Interim Guidance on the Use of Statin Therapy for the Primary Prevention of Cardiovascular Disease in People with HIV

Read more